Compound electrolytic fructose injection

Abstract

Disclosed is a compound electrolytic fructose injection for fluid replacement treatment in diuresis period after kidney transplantation surgery, wherein levulose is used for substituting glucose, for making compound injection with correct concentration range, The volume of the transfusion bottle and the transfusion bag is increased, thus simplifying transfusion operational program, reducing working capacity of fluid replacement treatment, and overcoming the possible pollution and error caused by frequent replacement of transfusion bottle or bag.

Description

technical field [0001] The invention relates to the technical field of medicine, and relates to a compound electrolyte fructose injection used for postoperative fluid infusion, and is especially suitable for fluid infusion treatment in polyuria period after kidney transplantation. Background technique [0002] Clinically, patients after surgery often cannot eat a large amount of food immediately, and need to replenish water, electrolytes and calories from the veins. Electrolyte solutions are also needed during hemorrhagic shock from surgery or trauma. Most of the commonly used rehydration schemes are to supplement electrolytes with balance fluid, and glucose solution to supplement the heat and water needed by the human body. However, because the body is in a state of stress after surgery or trauma, the ability to utilize glucose is reduced, and a large amount of glucose quickly input can not be fully utilized by the body, but also can lead to a significant increase in blood...

AI Technical Summary

Problems solved by technology

At the same time, when the urine sugar increases, the osmotic diuretic effect of glucose will cause important ions such as sodium and potassium in the patient's body and water to be lost with the urine, thereby increasing the possibility of water and electrolyte disorders.